"
"
The pharmaceutical business Duopharma Biotech Bhd is the first to achieve halal certification for an anticancer product.
The organization said in a statement today that the Department of Islamic Development Malaysia had granted the certification (JAKIM).
A first-line treatment for postmenopausal women with advanced breast cancer as well as an adjuvant treatment for postmenopausal women with early breast cancer are both currently approved uses for the product.
The halal cancer product is produced at Duopharma Biotech’s Highly Potent Active Pharmaceutical Ingredients (HAPI) plant in Glenmarie, Shah Alam, and is distributed to both public and private hospitals in Malaysia.
Singapore and Brunei have recently received export approval for it.
Leonard Ariff Abdul Shatar, group managing director of Duopharma Biotech, stated that the company’s dedication to ESG was in line with the milestone halal certification for an oncology medication produced at its HAPI facility.
therapies – assured safe for use and effective, high in quality, hygienic and halal from the start.
“Our state-of-the-art HAPI facility plays a vital role in the fight against many diseases, enabling us to embrace innovation and technology to serve patient needs and expand access to specialized therapies,” he said.
The company’s entry into the oncology market in 2019 was launched with the opening of Duopharma Biotech’s HAPI plant, the country’s first manufacturing facility for cancer medications. At the moment, the factory creates generic drugs to treat blood, breast, lung, colorectal, and cervical cancers.
In accordance with MS 1500:2009 requirements, Duopharma Biotech has been developing a variety of Halal-certified health supplements since 1999. These products include CHAMPS, Flavettes, Proviton, and Naturalle.
